CZR(CZR)
CZR
Q3 2026 EPS Estimate
$0.05
Aug 4, 2026 · Reports after close
Revenue Estimate
$2.97B
FY2027E EPS$0.34
FY2028E EPS$0.48
Analyst Sentiment
Wall St. Consensus
Hold29 analysts·High coverage
59
Score
11 Buy (38%)17 Hold (59%)1 Sell (3%)
Rating Breakdown
Strong Buy
13%
Buy
1034%
Hold
1759%
Sell
13%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$26.00
-12.8%
Consensus
$31.00
+4.0%
Bull
$35.00
+17.4%
12-Month Target Range29 analysts
$26.00$31.00$35.00
Current $29.82Consensus
Current Price
$29.82
Upside to Consensus
$1.18
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+2.47%
EPS—
FY2028
Rev+1.48%
EPS+40.35%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $11.82B | $12.12B | $12.30B |
| Low | $11.72B | $11.81B | $12.23B |
| High | $11.93B | $12.45B | $12.36B |
| EBITDA Avg | $4.31B | $4.42B | $4.48B |
| Low | $4.27B | $4.30B | $4.46B |
| High | $4.35B | $4.54B | $4.51B |
| EBIT Avg | $2.77B | $2.84B | $2.88B |
| Low | $2.75B | $2.77B | $2.87B |
| High | $2.80B | $2.92B | $2.90B |
| Net Income Avg | $-123M | $102M | $228M |
| Low | $-142M | $15M | $14M |
| High | $-81M | $163M | $257M |
| EPS Avg | $-0.50 | $0.34 | $0.48 |
| Low | $-0.68 | $0.07 | $0.07 |
| High | $-0.39 | $0.79 | $1.24 |
| Analysts (Rev / EPS) | 14 / 7 | 13 / 8 | 7 / 5 |
Quarterly
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.97B | $2.97B | $3.02B | $2.94B | $3.03B | $3.03B | $3.08B | $2.96B |
| Low | $2.96B | $2.94B | $2.97B | $2.90B | $2.99B | $2.99B | $3.03B | $2.92B |
| High | $3.01B | $3.01B | $3.07B | $2.99B | $3.08B | $3.08B | $3.13B | $3.01B |
| EBITDA Avg | $1.08B | $1.08B | $1.10B | $1.07B | $1.11B | $1.10B | $1.12B | $1.08B |
| Low | $1.08B | $1.07B | $1.08B | $1.06B | $1.09B | $1.09B | $1.11B | $1.06B |
| High | $1.10B | $1.10B | $1.12B | $1.09B | $1.12B | $1.12B | $1.14B | $1.10B |
| EBIT Avg | $696M | $696M | $707M | $689M | $711M | $711M | $722M | $694M |
| Low | $694M | $689M | $696M | $679M | $700M | $700M | $711M | $684M |
| High | $706M | $706M | $719M | $701M | $723M | $722M | $734M | $706M |
| Net Income Avg | $9M | $-5M | $-8M | $-15M | $40M | $35M | $14M | $-8M |
| Low | $-4M | $-12M | $-8M | $-16M | $39M | $34M | $14M | $-8M |
| High | $24M | $5M | $-8M | $-15M | $41M | $35M | $14M | $-8M |
| EPS Avg | $0.05 | $-0.03 | $-0.04 | $-0.08 | $0.20 | $0.17 | $0.07 | $-0.04 |
| Low | $-0.02 | $-0.06 | $-0.04 | $-0.08 | $0.19 | $0.17 | $0.07 | $-0.04 |
| High | $0.12 | $0.03 | $-0.04 | $-0.07 | $0.20 | $0.17 | $0.07 | $-0.04 |
| Analysts (Rev / EPS) | 11 / 5 | 11 / 4 | 5 / 2 | 5 / 2 | 6 / 1 | 9 / 1 | 5 / 2 | 4 / 3 |